Indication
Enterobacter complicated UTI
An Enterobacter complicated urinary tract infection (cUTI) is an infection of the urinary system caused by gram-negative bacilli of the genus *Enterobacter* (predominantly the *Enterobacter cloacae* complex) occurring in the presence of factors that compromise urinary tract function or host defenses. Read more about Enterobacter complicated UTI
97 drugs 57 manufacturers
Drugs that treat it
Common Enterobacter complicated UTI therapies.
AVYCAZ (ceftazidime/avibactam sodium)
TOBRAMYCIN SULFATE IN NS (tobramycin sulfate/sodium chloride)
TAZICEF (ceftazidime)
TAZICEF (ceftazidime)
TAZICEF (ceftazidime)
TAZICEF (ceftazidime)
CEFTRIAXONE (ceftriaxone sodium)
CEFTRIAXONE (ceftriaxone sodium)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAn Enterobacter complicated urinary tract infection (cUTI) is an infection of the urinary system caused by gram-negative bacilli of the genus *Enterobacter* (predominantly the *Enterobacter cloacae* complex) occurring in the presence of factors that compromise urinary tract function or host defenses.
It characteristically affects hospitalized, catheterized, or immunocompromised individuals, as well as patients with structural or functional urinary tract abnormalities, such as neurogenic bladder, urinary tract instrumentation, or nephrolithiasis.
Pathophysiologically, the infection can extend beyond the bladder mucosa to involve the upper urinary tract or deep tissues, presenting clinically with pyuria, bacteriuria, fever, flank pain, costovertebral angle tenderness, and a heightened risk of bacteremia and urosepsis.
These infections pose significant clinical management challenges due to the organism's intrinsic inducible chromosomal AmpC beta-lactamase production and potential for multidrug resistance.
- cdc.gov
An Enterobacter complicated urinary tract infection (cUTI) is an infection of the urinary system caused by gram-negative bacilli of the genus *Enterobacter* (predominantly the *Enterobacter cloacae* complex) occurring in the presence of factors that compromise urinary tract function or host defenses
- nih.gov
An Enterobacter complicated urinary tract infection (cUTI) is an infection of the urinary system caused by gram-negative bacilli of the genus *Enterobacter* (predominantly the *Enterobacter cloacae* complex) occurring in the presence of factors that compromise urinary tract function or host defenses It characteristically affects hospitalized, catheterized, or immunocompromised individuals, as well as patients with structural or functional urinary tract abnormalities, such as neurogenic bladder, ...
- nih.gov
An Enterobacter complicated urinary tract infection (cUTI) is an infection of the urinary system caused by gram-negative bacilli of the genus *Enterobacter* (predominantly the *Enterobacter cloacae* complex) occurring in the presence of factors that compromise urinary tract function or host defenses It characteristically affects hospitalized, catheterized, or immunocompromised individuals, as well as patients with structural or functional urinary tract abnormalities, such as neurogenic bladder, ...
- nih.gov
Pathophysiologically, the infection can extend beyond the bladder mucosa to involve the upper urinary tract or deep tissues, presenting clinically with pyuria, bacteriuria, fever, flank pain, costovertebral angle tenderness, and a heightened risk of bacteremia and urosepsis
- unmc.edu
Pathophysiologically, the infection can extend beyond the bladder mucosa to involve the upper urinary tract or deep tissues, presenting clinically with pyuria, bacteriuria, fever, flank pain, costovertebral angle tenderness, and a heightened risk of bacteremia and urosepsis
- uspharmacist.com
Pathophysiologically, the infection can extend beyond the bladder mucosa to involve the upper urinary tract or deep tissues, presenting clinically with pyuria, bacteriuria, fever, flank pain, costovertebral angle tenderness, and a heightened risk of bacteremia and urosepsis
- nih.gov
Pathophysiologically, the infection can extend beyond the bladder mucosa to involve the upper urinary tract or deep tissues, presenting clinically with pyuria, bacteriuria, fever, flank pain, costovertebral angle tenderness, and a heightened risk of bacteremia and urosepsis
- nih.gov
These infections pose significant clinical management challenges due to the organism's intrinsic inducible chromosomal AmpC beta-lactamase production and potential for multidrug resistance
- nih.gov
These infections pose significant clinical management challenges due to the organism's intrinsic inducible chromosomal AmpC beta-lactamase production and potential for multidrug resistance
Personalize your experience
Follow Enterobacter complicated UTI and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.